News summary

Milestone FDA Clearance paves way for Multiwave U.S. Launch

Source: Startupticker.ch • Published: 20 Nov 2026, 00:00

Summarized by Masters of Longevity from Startupticker.ch.

Geneva medtech received FDA clearance for its MGNTQv0 portable brain MRI, enabling US launch.

Milestone FDA Clearance paves way for Multiwave U.S. Launch
Key Takeaways
  • MGNTQv0 is cleared for initial authorized clinical use in the US.
  • Company is preparing US commercial rollout and assembly scaling in Lowell.
  • Ongoing studies and collaborations are continuing to expand device evidence.
Read the full article at Startupticker.ch ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?